Navigation Links
Stephen H. Friend, MD, PhD to Keynote at Defined Health's 9th Annual Therapeutic Insight Conference
Date:2/25/2009

FLORHAM PARK, N.J., Feb. 25 /PRNewswire/ -- Defined Health has announced the agenda and confirmed speakers for its 9th annual Therapeutic Insight conference. Therapeutic Insight 2009 ("TI2009") will take place on March 31- April 2, 2009, at The New York Marriott Downtown. The agenda, list of speakers and registration information along with content and attendee statistics from prior Therapeutic Insight conferences are available on the conference website, www.therapeuticinsight.com.

The following industry and key opinion leaders are among those who will discuss key industry issues and trends in oncology, pain, COPD, biologics and frailty in aging:

  • John Babiak, PhD, SVP, Discovery Technologies, PTC Therapeutics, Inc.
  • Karen Bernstein, PhD, Chairman & Editor-in-Chief, BioCentury
  • Maria Paola Chiesi, PhD, Corporate Marketing Head, Chiesi Farmaceutici
  • James F. Donohue, MD, Chief of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill School of Medicine
  • Andy Dray, PhD, Chief Scientist, AstraZeneca R & D, Montreal, Canada
  • Mark Edwards, Principal, Deloitte Recap LLC
  • Thomas M. Estok, President & CEO, Tragara Pharmaceuticals Inc.
  • Alan Ezekowitz, PhD, SVP & Franchise Head, BRIE, Merck Research Laboratories
  • Frederick Frank, Vice Chairman, Barclays Capital
  • Stephen H. Friend, MD, PhD, SVP & Franchise Head, Oncology, Merck Research Laboratories
  • Steve Hoerter, Sr. Director, BioOncology Marketing and Pipeline Commercial Development, Genentech BioOncology
  • Tamar Howson, MS, MBA, Partner, JSB-Partners
  • Martin Meglasson, PhD, VP, Discovery Research, Ligand Pharmaceutical
  • Scott Mellis, MD, PhD, VP, Translational Medicine, Regeneron Pharmaceuticals, Inc.
  • Stelios Papadopoulos, PhD
  • Daniele Piomelli, PhD, Louise Turner Arnold Chair in the Neurosciences, Professor of Pharmacology and Biological Chemistry, Director, Center for Drug Discovery, University of California, Irvine
  • Sherrie Preische, PhD, Director, Business Development, Genmab, Inc.
  • Dennis J. Purcell, MBA, Senior Managing Partner, Aisling Capital, LLC
  • Eric Rowinsky, MD, EVP & Chief Medical Officer, ImClone
  • Edward C. Saltzman, President, Defined Health
  • William K. Schmidt, PhD, President, NorthStar Consulting, LLC
  • Paul J. Sekhri, Head, Biotech Ops Group, TPG Biotech/TPG Growth, LLC
  • David Shen, PhD, Executive Director, Biologics Research and GlycoFi, Merck & Co.
  • Mark J. Simon, President, Williver Group
  • Anders Ullman, MD, PhD, EVP, Research & Development, Nycomed
  • Kenneth M. Verburg, PhD, VP, PGRD Therapeutic Area Development Group Head, Pfizer
  • Robert E. Ward, VP, Corporate Development, NPS Pharmaceuticals

Stephen H. Friend, MD, PhD, SVP & Franchise Head, Oncology Merck Research Laboratories, will present a keynote address at TI2009 entitled, "Emerging Approaches for Translational Medicine: How One Might Break Through Existing Clinical Inefficiencies; Open Access Bionetwork Platforms as Contributor Engines to Evolve Disease Models."

The 2+ day conference will include 2 networking events and additional networking opportunities throughout the event. After a welcome reception on Tuesday, March 31, the conference will begin on Wednesday morning, April 1, with a plenary presentation by Ed Saltzman, President of Defined Health, entitled: "On a Dime and In Very Little Time: Biotech's New Value Creation Challenge."

Therapeutic Insight 2009 is sponsored by Defined Health and Communitech Market Intelligence. To register, or for more information, please visit www.therapeuticinsight.com, or contact:

Communitech: (914) 245-7764, www.cmius.com

Defined Health: (973) 292-5001 X 235, www.definedhealth.com.

    Contact:
    Ginny E. Llobell
    Vice President
    Defined Health
    973-292-5001 X 235


'/>"/>
SOURCE Defined Health
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
2. Genomic Health to Present at Stephens Fall Investment Conference
3. Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
4. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
5. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
6. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
7. Nano-Bio-Info-Cogno Revolutions to be Explored at Convergence08 Unconference - Forecaster Paul Saffo to Keynote
8. Christine Poon Will Keynote MichBio Expo
9. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
10. Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference
11. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... Scottsdale, AZ (PRWEB) , ... June 27, 2017 ... ... the world’s first brain mirroring wellness product via Kickstarter campaign on June 15th ... backers have already pre-ordered the B2v2, exceeding the original Kickstarter goal by more ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... design for its patented GX-1 yeast production and fermentation process. The efficiencies ... that rely on micro-organism technologies, most notably the ethanol industry wherein individual production ...
(Date:6/26/2017)... ... June 26, 2017 , ... Third Wave Bioactives, LLC announces the addition ... on leading new business development and ensuring quality customer experience. , Brett ... ingredient industry in technical, marketing and sales roles. “Brett’s background working with customers and ...
(Date:6/23/2017)... ... June 23, 2017 , ... Biova, LLC., the leader in ... Biova’s Board of Directors. Dr. Henig will bring a wealth of scientific experience in ... as the Chief Technical and Scientific Officer of four major global companies in the ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):